These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7989993)

  • 21. Thallium-201 scanning: some pharmacologic interventions.
    Blend MJ
    J Am Osteopath Assoc; 1987 Dec; 87(12):816-24. PubMed ID: 3323148
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacological interventional testing for myocardial perfusion: a new application for adenosine.
    McNulty SA
    Cardiovasc Nurs; 1992; 28(4):24-8. PubMed ID: 1606589
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical decision making: dipyridamole thallium imaging.
    Gill JB; Miller DD; Boucher CA; Strauss HW
    J Nucl Med; 1986 Jan; 27(1):132-7. PubMed ID: 3941357
    [No Abstract]   [Full Text] [Related]  

  • 24. The incidence of serious hemodynamic changes in physically-limited patients following oral dipyridamole challenge before thallium-201 scintigraphy.
    Kahn D; Argenyi EA; Berbaum K; Rezai K
    Clin Nucl Med; 1990 Oct; 15(10):678-82. PubMed ID: 2225669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of exercise supplementation on dipyridamole thallium-201 image quality.
    Stern S; Greenberg ID; Corne R
    J Nucl Med; 1991 Aug; 32(8):1559-64. PubMed ID: 1869979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.
    Brown KA
    Circulation; 1991 Feb; 83(2):363-81. PubMed ID: 1991361
    [No Abstract]   [Full Text] [Related]  

  • 27. Dipyridamole/thallium-201 imaging: how safe is it? When should it be used?
    Kaul S; Villanueva FS
    J Nucl Med; 1991 Nov; 32(11):2115-7. PubMed ID: 1941147
    [No Abstract]   [Full Text] [Related]  

  • 28. [Myocardial gammagraphy with thallium-201 and low-doses dipyridamole. Prediction of coronary lesions from segmental defects in perfusion].
    Martínez Martínez A; Sánchez A; Ramos A; Latre JM; Fournier JA; Errazquin F; Burgos J
    Rev Esp Cardiol; 1987; 40(3):169-74. PubMed ID: 3628911
    [No Abstract]   [Full Text] [Related]  

  • 29. Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration.
    Boudreau RJ; Strony JT; duCret RP; Kuni CC; Wang Y; Wilson RF; Schwartz JS; Castaneda-Zuniga WR
    Radiology; 1990 Apr; 175(1):103-5. PubMed ID: 2315467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dipyridamole-thallium imaging: minimum dose requirements.
    LaBonté C; Lette J; Cerino M; Gagnon A; Waters D
    Can J Cardiol; 1991 Sep; 7(7):295-7. PubMed ID: 1933635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole-body imaging of thallium-201 after six different stress regimens.
    Pennell DJ; Ell PJ
    J Nucl Med; 1994 Mar; 35(3):425-8. PubMed ID: 8113888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transient neurological events during dipyridamole stress test: an arterial steal phenomenon?
    Schechter D; Bocher M; Berlatzky Y; Anner H; Argov Z; Beer G; Krausz Y; Gotsman MS; Chisin R
    J Nucl Med; 1994 Nov; 35(11):1802-4. PubMed ID: 7965160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine and dipyridamole myocardial scintigraphy.
    Iskandrian AS; Heo J
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):73-81. PubMed ID: 1450250
    [No Abstract]   [Full Text] [Related]  

  • 34. Dipyridamole thallium scintigraphy and prognosis in coronary artery disease.
    Willerson JT
    J Am Coll Cardiol; 1990 Jan; 15(1):117-8. PubMed ID: 2295719
    [No Abstract]   [Full Text] [Related]  

  • 35. [Myocardial 201T1 perfusion scintigraphy with the exercise test and/or with dipyridamole in the diagnosis of ischemic cardiopathies].
    Picozzi R; Palagi B; Roda L; Tarolo GL
    Radiol Med; 1980 Nov; 66(11):828-30. PubMed ID: 7221050
    [No Abstract]   [Full Text] [Related]  

  • 36. [Usefulness and limitations of stress 201-thallium myocardial imaging in patients with Kawasaki disease].
    Ono Y; Kohata T; Iwatani H; Okuno M; Suzuki A; Kamiya T; Nishimura T; Takamiya M
    J Cardiol; 1991; 21(2):437-44. PubMed ID: 1841930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Indication and assessment of coronary artery bypass grafting].
    Shio K; Okada M; Sato H; Nishiwaki M; Ota M; Nakamura K; Omori Y; Fukuzaki T
    J Cardiol Suppl; 1989; 22():15-6. PubMed ID: 2640860
    [No Abstract]   [Full Text] [Related]  

  • 38. A look at 15 years of planar thallium-201 imaging.
    Kaul S
    Am Heart J; 1989 Sep; 118(3):581-601. PubMed ID: 2672756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of dipyridamole thallium imaging in a patient with myocardial bridging but without fixed obstructive coronary artery disease.
    Rivitz SM; Yasuda T
    J Nucl Med; 1992 Oct; 33(10):1905-13. PubMed ID: 1403164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thallium-201-dipyridamole imaging: comparison between a standard dose and a high dose of dipyridamole in the detection of coronary artery disease.
    Lalonde D; Taillefer R; Lambert R; Bisson G; Basile F; Prieto I; Benjamin C
    J Nucl Med; 1994 Aug; 35(8):1245-53. PubMed ID: 8046475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.